The Role of Negative-Pressure Wound Therapy in Patients with Fracture-Related Infection: A Systematic Review and Critical Appraisal
Overview
Biotechnology
General Medicine
Authors
Affiliations
Introduction: Fracture-related infection (FRI) is a severe musculoskeletal complication in orthopedic trauma surgery, causing challenges in bony and soft tissue management. Currently, negative-pressure wound therapy (NPWT) is often used as temporary coverage for traumatic and surgical wounds, also in cases of FRI. However, controversy exists about the impact of NPWT on the outcome in FRI, specifically on infection recurrence. Therefore, this systematic review qualitatively assesses the literature on the role of NPWT in the management of FRI.
Methods: A literature search of the PubMed, Embase, and Web of Science database was performed. Studies that reported on infection recurrence related to FRI management combined with NPWT were eligible for inclusion. Quality assessment was done using the PRISMA statement and the Newcastle-Ottawa Quality Assessment Scale.
Results: After screening and quality assessment of 775 unique identified records, eight articles could be included for qualitative synthesis. All eight studies reported on infection recurrence, which ranged from 2.8% to 34.9%. Six studies described wound healing time, varying from two to seven weeks. Four studies took repeated microbial swabs during subsequent vacuum dressing changes. One study reported newly detected pathogens in 23% of the included patients, and three studies did not find new pathogens.
Conclusion: This review provides an assessment of current literature on the role of NPWT in the management of soft tissue defects in patients with FRI. Due to the lack of uniformity in included studies, conclusions should be drawn with caution. Currently, there is no clear scientific evidence to support the use of NPWT as definitive treatment in FRI. At this stage, we can only recommend early soft tissue coverage (within days) with a local or free flap. NPWT may be safe for a few days as temporarily soft tissue coverage until definitive soft tissue management could be performed. However, comparative studies between NPWT and early wound closure in FRI patients are needed.
Current Concepts and Investigations of Fracture-Related Infection.
Jiang N, Xu C, Stoodley P, McNally M Biomed Res Int. 2025; 2025:9768347.
PMID: 39949371 PMC: 11824792. DOI: 10.1155/2025/9768347.
Medic B, Tomic N, Lagopati N, Gazouli M, Pojskic L Molecules. 2024; 29(23.
PMID: 39683711 PMC: 11643765. DOI: 10.3390/molecules29235551.
Pathogens in FRI - Do bugs matter? - An analysis of FRI studies to assess your enemy.
Thompson E, Qureshi A J Orthop. 2024; 53:59-72.
PMID: 38476676 PMC: 10925936. DOI: 10.1016/j.jor.2024.02.011.
Cong B, Chen M Int Wound J. 2024; 21(1):e14650.
PMID: 38272791 PMC: 10794078. DOI: 10.1111/iwj.14650.
[Treatment strategies for fracture-related infections with concurrent soft tissue damage].
Alt V, Rupp M, Kerschbaum M, Prantl L, Geis S Unfallchirurgie (Heidelb). 2024; 127(2):103-109.
PMID: 38167783 DOI: 10.1007/s00113-023-01403-z.